Strategy
meets
Execution.
I step in when growth stalls and results cannot wait.
I build pipeline, close deals, and create European growth.
By Ivo Schefman – Execution Expert in Life Sciences
Identify Bottlenecks
Structure & Partners
Commercial Ownership
funding raised
concept to patient
lab built
Professional experience across leading healthcare organizations
Ervaring bij toonaangevende healthcare organisaties
Where I step in
Waar ik instap
Select your current challenge
Interim Leadership
Fix stalled growth, own pipeline, and close deals when your commercial team needs direct leadership.
European Market Entry
Strategic validation to first revenue. Establish a compliant and scalable presence in the complex EU market.
Build & Scale
From concept to patient. Set up the structure, partner networks, and commercial engine for sustained success.
Avoid 12–24 months delay entering the EU market.
I take ownership from strategy to first revenue.
Market Validation
- • Identify priority countries
- • Demand and pricing check
- • Reimbursement pathways
Regulatory & Legal
- • CE, MDR, IVDR pathways
- • Legal entity setup
- • Compliance partners
Commercial Build
- • Open key accounts
- • Distributor vs direct
- • Value propositions
Operations
- • GDP logistics & fulfillment
- • Returns, repair, setup
- • Admin and IT systems
Execution
- • First deals closed
- • Local traction established
- • Scalable growth structure
The Strategic Ecosystem
Direct Access to Proven Partners.
Successful market entry requires more than strategy. I provide immediate access to a vetted network of experts across Europe to handle regulatory complexity and physical distribution.
- MDR/IVDR Experts
- CDMO & CMO Network
- GDP Logistics
- Market Access
"I navigate the fragmented landscape of European regulations so you can focus on building your brand. I build the infrastructure, you provide the innovation."
Interim Business Development & Market Lead
Direct commercial ownership when results cannot wait. I step in to fix stalled growth, build qualified pipeline, and close critical deals.
Typical Mandates
- / Bridging the gap for a senior full-time hire
- / Accelerating European expansion plans
- / Achieving commercial traction for next-stage funding
- / Closing complex, technical MedTech/Pharma deals
Outcomes (3–6 mo)
- First key accounts closed
- Qualified and active pipeline
- Strategic partnerships secured
- Structure ready for scale
Startup Development & Funding
I support innovators from concept to patient.
The Trajectory
- 1. Business plan & positioning
- 2. Investor-ready decks & funding strategy
- 3. Commercial model & global setup
- 4. Preparing investor discussions
Funding Support
I assist in structuring applications for regional programs (LIOF, BOM) to partially fund building activities.
Track Record
raised
concept to patient
"In selected cases, I invest alongside founders where there is a strong strategic fit."